Maven Securities’s Cerevel Therapeutics Holdings, Inc. Warrant CEREW Stock Holding History

Maven Securities’s Portfolio CEREW Stock Details CEREW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-56,667	Closed	-$855K	–	1444
2021 Q2	$855K	Hold	56,667	–	–	0.03%	487
2021 Q1	$204K	Hold	56,667	–	–	0.01%	919
2020 Q4	$338K	Buy	+56,667	New	+$229K	0.03%	409

Maven Securities's CEREW Position: Q3 2021 in Review

Maven Securities sold out of Cerevel Therapeutics Holdings, Inc. Warrant (CEREW) in Q3 2021, closing a stake of 56,667 shares — an estimated $855K sold.

Maven Securities first reported a position in CEREW in Q4 2020 and held it in 3 quarters. The position peaked at $855K in Q2 2021. 0 funds tracked by Wall St. Rank hold CEREW as of Q3 2021.

Maven Securities reported no remaining Cerevel Therapeutics Holdings, Inc. Warrant position as of Q3 2021 after selling out during the quarter.
Maven Securities sold 56,667 Cerevel Therapeutics Holdings, Inc. Warrant shares in Q3 2021, an estimated $855K.
Maven Securities first reported a position in Cerevel Therapeutics Holdings, Inc. Warrant in Q4 2020 and held it in 3 quarters.
Maven Securities's Cerevel Therapeutics Holdings, Inc. Warrant position peaked at $855K in Q2 2021.
0 funds tracked by Wall St. Rank held Cerevel Therapeutics Holdings, Inc. Warrant as of Q3 2021.

Based on Maven Securities's 13F filing for Q3 2021, filed 15 Nov 2021.